The fourth pillar: Despite some setbacks in the clinic, immunotherapy has made notable progress toward becoming an additional therapeutic option against cancer

Abstract

Immunotherapy based on anti‐cancer vaccines and checkpoint inhibitors of the immune system could become the fourth therapeutic approach to treat cancer. It still requires a better understanding of how and against which cancers it is most efficient.